NEDD4 binds to and mediates polyubiquitination of IGPR-1 leading to its lysosomal-dependent degradation, suggesting a significant role for NEDD4 in modulating IGPR-1 expression in melanoma and other human cancers. Here, TMIGD2 is linked to cancer.